Clinical Trial Update: Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg [Phase 3]

View source ↗

Summary

Phase 3 trial update on therapeutic equivalence between fluticasone propionate inhaler 110 mcg and Flovent HFA 110 mcg in asthma was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flovent HFA 110 mcg (fluticasone propionate)
• Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg (fluticasone propionate)

Snippet

Sponsor: Actavis Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED